Loading...
XSTO
RAY B
Market cap816mUSD
Jul 10, Last price  
234.00SEK
1D
0.60%
1Q
18.36%
Jan 2017
26.83%
Name

RaySearch Laboratories AB (publ)

Chart & Performance

D1W1MN
XSTO:RAY B chart
P/E
34.83
P/S
5.90
EPS
6.72
Div Yield, %
1.29%
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
15.58%
Revenues
1.34b
+12.77%
68,976,00064,705,00062,690,00083,687,000117,728,000126,103,000182,087,000204,470,000285,217,000397,600,000531,468,000585,086,000627,219,000741,584,000651,612,000641,673,000843,648,0001,022,159,0001,192,029,0001,344,300,000
Net income
228m
+11.93%
36,219,00019,779,00018,223,00030,146,00028,895,00017,007,00019,863,000-20,841,00059,832,00070,209,000151,408,000117,627,00078,523,00050,411,000-9,080,000-47,315,00023,778,00081,572,000203,513,000227,800,000
CFO
387m
-20.24%
30,093,00037,862,00026,045,00049,207,00062,785,00033,852,00087,451,00031,282,00050,273,000111,426,000120,848,000147,481,000178,472,000320,145,000331,508,000238,162,000356,777,000455,931,000485,230,000387,000,000
Dividend
May 08, 20264 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

RaySearch Laboratories AB (publ) is a global medical technology company dedicated to developing cutting-edge software solutions for cancer treatment. Its principal offering, RayStation, is a sophisticated treatment planning system that supports a vast range of clinical activities. These capabilities include automated planning, adaptive therapy, multi-criteria optimization, rapid and accurate dose calculations, OAR dose reduction, robustness modeling, machine learning integration, and support for advanced radiation modalities such as VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic treatments, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also offers RayPlan, another treatment planning system specifically designed for various radiation therapy methods including 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy. For managing oncology workflows, RayCare serves as a dedicated information system. Additionally, RaySearch provides RayCommand, a flexible treatment control system compatible with diverse hardware and designed to manage advanced functionalities of treatment machines and software. To leverage patient data, its cloud-based oncology analytics system, RayIntelligence, converts raw information into valuable insights. RaySearch Laboratories AB (publ) further provides training courses for its products and is headquartered in Stockholm, Sweden.
IPO date
May 29, 1990
Employees
375
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT